This Talkspace Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Kairos Pharma, Ltd. KAPA with a Buy rating and announced a price target of $12. Kairos Pharma shares closed at $0.9185 on Wednesday. See how other analysts view this stock.
  • Canaccord Genuity analyst Richard Close initiated coverage on Talkspace, Inc. TALK with a Buy rating and announced a price target of $5. Talkspace shares closed at $2.79 on Wednesday. See how other analysts view this stock.
  • Janney Montgomery Scott analyst John Rodis initiated coverage on Equity Bancshares, Inc. EQBK with a Neutral rating. Equity Bancshares shares closed at $39.55 on Wednesday. See how other analysts view this stock.
  • Canaccord Genuity analyst Richard Close initiated coverage on LifeStance Health Group, Inc. LFST with a Buy rating and announced a price target of $8. LifeStance Health shares closed at $6.63 on Wednesday. See how other analysts view this stock.

Considering buying TALK stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

EQBK Logo
EQBKEquity Bancshares Inc
$38.391.59%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
68.17
Growth
98.10
Quality
40.84
Value
-
Price Trend
Short
Medium
Long
Got Questions? Ask
How will Kairos Pharma perform after a Buy rating?
What factors could drive Talkspace shares towards $5?
Which investors are targeting Equity Bancshares now?
Could LifeStance Health benefit from the bullish outlook?
What market trends support Talkspace's growth potential?
Is there a growing demand for telehealth services impacting these stocks?
How might analyst ratings influence investor sentiment?
Which healthcare stocks could see a ripple effect from Talkspace?
Are there upcoming earnings reports for Kairos Pharma to watch?
What risks could LifeStance Health face despite the positive rating?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Comments
Loading...